169 related articles for article (PubMed ID: 19623182)
1. Androgen-related expression of G-proteins in ovarian cancer.
Sheach LA; Adeney EM; Kucukmetin A; Wilkinson SJ; Fisher AD; Elattar A; Robson CN; Edmondson RJ
Br J Cancer; 2009 Aug; 101(3):498-503. PubMed ID: 19623182
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer.
Elattar A; Warburton KG; Mukhopadhyay A; Freer RM; Shaheen F; Cross P; Plummer ER; Robson CN; Edmondson RJ
Gynecol Oncol; 2012 Jan; 124(1):142-7. PubMed ID: 22001143
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
Evangelou A; Jindal SK; Brown TJ; Letarte M
Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107
[TBL] [Abstract][Full Text] [Related]
4. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo.
Fan Y; Xin XY; Chen BL; Ma X
Pathology; 2006 Dec; 38(6):561-7. PubMed ID: 17393986
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progression.
Butler MS; Ricciardelli C; Tilley WD; Hickey TE
Horm Cancer; 2013 Jun; 4(3):154-64. PubMed ID: 23443946
[TBL] [Abstract][Full Text] [Related]
7. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.
Cheng KW; Lahad JP; Kuo WL; Lapuk A; Yamada K; Auersperg N; Liu J; Smith-McCune K; Lu KH; Fishman D; Gray JW; Mills GB
Nat Med; 2004 Nov; 10(11):1251-6. PubMed ID: 15502842
[TBL] [Abstract][Full Text] [Related]
8. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
[TBL] [Abstract][Full Text] [Related]
9. Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system.
Ling K; Jiang L; Liang S; Kwong J; Yang L; Li Y; PingYin ; Deng Q; Liang Z
J Ovarian Res; 2018 May; 11(1):36. PubMed ID: 29716628
[TBL] [Abstract][Full Text] [Related]
10. Rab25 is responsible for phosphoinositide 3-kinase/AKT‑mediated cisplatin resistance in human epithelial ovarian cancer cells.
Fan Y; Wang L; Han X; Liu X; Ma H
Mol Med Rep; 2015 Mar; 11(3):2173-8. PubMed ID: 25405658
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of RAB25 promotes autophagy and inhibits cell growth in ovarian cancer cells.
Liu Y; Tao X; Jia L; Cheng KW; Lu Y; Yu Y; Feng Y
Mol Med Rep; 2012 Nov; 6(5):1006-12. PubMed ID: 22940905
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands.
Ahonen MH; Zhuang YH; Aine R; Ylikomi T; Tuohimaa P
Int J Cancer; 2000 Apr; 86(1):40-6. PubMed ID: 10728592
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer.
Gomez-Roman N; Sahasrabudhe NM; McGregor F; Chalmers AJ; Cassidy J; Plumb J
Oncotarget; 2016 Apr; 7(16):22650-64. PubMed ID: 26967059
[TBL] [Abstract][Full Text] [Related]
14. Expression of 5alpha-reductases in human epithelial ovarian cancer: its correlation with androgen receptor status.
Akahira JI; Suzuki T; Ito K; Darnel AD; Moriya T; Sato S; Yaegashi N; Okamura K; Sasano H
Jpn J Cancer Res; 2001 Sep; 92(9):926-32. PubMed ID: 11572759
[TBL] [Abstract][Full Text] [Related]
15. Loss of coordinated androgen regulation in nonmalignant ovarian epithelial cells with BRCA1/2 mutations and ovarian cancer cells.
Evangelou A; Letarte M; Jurisica I; Sultan M; Murphy KJ; Rosen B; Brown TJ
Cancer Res; 2003 May; 63(10):2416-24. PubMed ID: 12750261
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of a conditionally immortalized human osteoblastic cell line stably transfected with the human androgen receptor gene.
Hofbauer LC; Hicok KC; Schroeder MJ; Harris SA; Robinson JA; Khosla S
J Cell Biochem; 1997 Sep; 66(4):542-51. PubMed ID: 9282332
[TBL] [Abstract][Full Text] [Related]
17. Increased androgen receptor levels and signaling in ovarian cancer cells by VEPH1 associated with suppression of SMAD3 and AKT activation.
Kollara A; Shathasivam P; Park S; Ringuette MJ; Brown TJ
J Steroid Biochem Mol Biol; 2020 Feb; 196():105498. PubMed ID: 31614206
[TBL] [Abstract][Full Text] [Related]
18. Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.
Jeong BY; Cho KH; Jeong KJ; Park YY; Kim JM; Rha SY; Park CG; Mills GB; Cheong JH; Lee HY
Exp Mol Med; 2018 Jan; 50(1):e435. PubMed ID: 29371698
[TBL] [Abstract][Full Text] [Related]
19. Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells.
Zhu ML; Kyprianou N
FASEB J; 2010 Mar; 24(3):769-77. PubMed ID: 19901020
[TBL] [Abstract][Full Text] [Related]
20. Regulated expression of the prostacyclin receptor (IP) gene by androgens within the vasculature: Combined role for androgens and serum cholesterol.
Eivers SB; Kinsella BT
Biochim Biophys Acta; 2016 Oct; 1859(10):1333-51. PubMed ID: 27365208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]